Skip to content

Connect Biopharma Holdings Ltd

CNTB

CIK 0001835268

← back to feed
Revenue (TTM)
$233K
−99.8% YoY Q1 Apr 2026
Net Income (TTM)
−$59.77M
−255.0% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.07
−257.1% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-26,676.0%
Q1 Apr 2026
Net Margin
-25,651.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$51.64M
Q1 Apr 2026
Cash
$46.03M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
62.96M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings